Moreover, Sal significantly reduced CHOP expression in cisplatin-induced injury in HEI-OC1 cells and cochleae, suggesting that Sal could also regulate the eIF2α-CHOP pathway to inhibit cisplatin-induced ERS in HCs. Here, EIF2A is linked to amelogenesis imperfecta type 1G.